Accordingly, SST and a related peptide, cortistatin-14, and the synthetic SSTR2, SSTR3, and SSTR5 agonist octreotide significantly reduce brain infarct size in a middle cerebral artery occlusion model (Rauca et al., 1999). Here, SSTR5 is linked to brain infarction.